- Home
- MRK vs C Comparison
MRK vs C Comparison
Compare MRK & C Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRK | C |
|---|---|---|
| Founded | 2000 | 1812 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.7B | 193.7B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | MRK | C |
|---|---|---|
| Price | $116.14 | $109.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 14 |
| Target Price | $123.21 | ★ $124.50 |
| AVG Volume (30 Days) | 10.1M | ★ 11.4M |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.83% | 2.16% |
| EPS Growth | ★ 8.01 | N/A |
| EPS | ★ 7.28 | N/A |
| Revenue | ★ $65,011,000,000.00 | N/A |
| Revenue This Year | $3.74 | $21.84 |
| Revenue Next Year | $5.47 | $3.86 |
| P/E Ratio | ★ $16.58 | $16.63 |
| Revenue Growth | ★ 1.31 | N/A |
| 52 Week Low | $75.40 | $55.51 |
| 52 Week High | $125.14 | $125.16 |
Technical Indicators
Market Signals| Indicator | MRK | C |
|---|---|---|
| Relative Strength Index (RSI) | 45.37 | 41.87 |
| Support Level | $105.23 | $92.68 |
| Resistance Level | $125.14 | $124.06 |
| Average True Range (ATR) | 2.77 | 3.59 |
| MACD | -0.99 | -0.52 |
| Stochastic Oscillator | 14.36 | 26.57 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About C Citigroup Inc.
Citigroup is a global financial-services company doing business in more than 160 countries and jurisdictions. Citigroup's operations are organized into five primary segments: services, markets, banking, US personal banking, and wealth management. The bank's primary services include cross-border banking needs for multinational corporates, investment banking and trading, and credit card services in the United States.